Biotechnology - Genomic and Proteomics/IP Profile of Biggest for-profit companies in BGP: Difference between revisions

From Commons Based Research
Jump to navigation Jump to search
No edit summary
 
(12 intermediate revisions by 2 users not shown)
Line 1: Line 1:
== What are the 10 biggest for-profit companies in this field?==
{{TOCright}}
(Correlated by Output - Data, Narratives, Tools)


'''note: Because creating single pages for each kind of output was becoming long and difficult to read, I have created a new page for each company. However, if this seems inefficient, I can quickly change it back'''
=Introduction=


===[[BGP Company Profiles - Data]]===
The US biotechnology industry includes about 1,000 companies, with combined annual revenue close to $50 billion. Large companies include [http://www.amgen.com/ Amgen], [http://www.monsanto.com/ Monsanto], [http://www.gene.com/gene/index.jsp Genentech], and [http://www.biogenidec.com/ Biogen]. The biotechnology and the pharmaceutical industries overlap considerably, since many drugs are now developed using biotechnology. The industry consists of a few very large companies and many very small ones, and is fragmented by type of product. Most companies have annual sales under $50 million. 


[[Amgen]]
Industry overview here: [http://bio.org/speeches/pubs/er/statistics.asp Biotechnology Industry Organization]


[[Genentech]]
Key Industry Statistics
Key Industry Figures 2008
* Industry Revenue: 85,695.4$Mil
* Revenue Growth: 12.9%
* Industry Gross Product: 58,539.2 $Mil
* Number of Establishments: 6,815 Units
* Number of Enterprises: 6,480 Units
* Employment: 341,000 Units
* Exports: 7,251$Mil
* Imports: 2,954.7$Mil
* Total Wages: *20,630.9$Mil
Source: [http://www.ibisworld.com/industry/retail.aspx?indid=2001&chid=1 Ibis World]


[[Genzyme]]
=[[BGP Company Profiles]]=
=[[Publishing Companies with focus on BGP]]=


[[Gilead Sciences]]
=Navigation=
 
* [[Bibliography for Item 6 in BGP]]<br>
[[Biogen Idec]]
* [[Biotechnology_-_Genomic_and_Proteomics]]
 
[[Cephalon]]
 
[[MedImmune]]
 
[[Celgene]]
 
[[Abraxis BioScience]]
 
[[ImClone Systems]]
 
For more information on these companies, see: [[BGP Table of Biggest For-Profit Companies]]
 
===[[BGP Company Profiles - Narratives]]===
 
[http://www.elsevier.com/wps/find/homepage.cws_home Elsevier]
 
[http://www.ncbi.nlm.nih.gov/pubmed/ PubMed]
 
[http://www.nature.com/ Nature]
 
[http://www.springer.com Springer]
 
[http://www.biomedcentral.com/ BioMedCentral]
 
===[[BGP Company Profiles - Tools]]===
 
==How is the market distributed?==
==Are there any incentives for specific locations?==
 
==Navigation==
[[Bibliography for Item 6 in BGP]]<br>
[[Biotechnology_-_Genomic_and_Proteomics]]

Latest revision as of 19:40, 22 April 2010

Introduction

The US biotechnology industry includes about 1,000 companies, with combined annual revenue close to $50 billion. Large companies include Amgen, Monsanto, Genentech, and Biogen. The biotechnology and the pharmaceutical industries overlap considerably, since many drugs are now developed using biotechnology. The industry consists of a few very large companies and many very small ones, and is fragmented by type of product. Most companies have annual sales under $50 million.

Industry overview here: Biotechnology Industry Organization

Key Industry Statistics Key Industry Figures 2008

  • Industry Revenue: 85,695.4$Mil
  • Revenue Growth: 12.9%
  • Industry Gross Product: 58,539.2 $Mil
  • Number of Establishments: 6,815 Units
  • Number of Enterprises: 6,480 Units
  • Employment: 341,000 Units
  • Exports: 7,251$Mil
  • Imports: 2,954.7$Mil
  • Total Wages: *20,630.9$Mil

Source: Ibis World

BGP Company Profiles

Publishing Companies with focus on BGP

Navigation

Retrieved from "http://cyber.harvard.edu/commonsbasedresearch/?title=Biotechnology_-_Genomic_and_Proteomics/IP_Profile_of_Biggest_for-profit_companies_in_BGP&oldid=6898"